Pharmafile Logo
Pharmafocus logo
Advanced Search
chemo-web

EUSA Pharma acquires global rights to oncology support drug

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Eusa Pharma, acroral, acroral tab, global rights, oncology

EUSA Pharma has announced the acquisition of global rights to oncology support care product, Arcoral Tab, from Arcoral Pharma.

News
regeneron

Regeneron agrees six-year $75 million upfront licencing deal with Intellia for gene technology

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing IPO, Intellia Therapeutics, Licencing, Regeneron Pharmaceuticals, crispr, deal, gene editing, genetics

Regeneron Pharmaceuticals Inc (Nasdaq: REGN) on Tuesday said it has signed a six-year licencing deal with biotech firm Intellia Therapeutics …

News
dollars_medicines

KaloBios announces new affordable pricing model, refuses to engage in “price gouging”

April 12, 2016
Manufacturing and Production, Sales and Marketing CEO, Drug pricing, KaloBios, Martin Shkreli, Shkreli, affordable, price gouging, price model, responsible

Price gouging has become synonymous with drug costs in the US, with the infamous Martin Shkreli and troubled Valeant becoming …

News
astrazeneca_sign_sky

Clinical studies point to consistent efficacy in AstraZeneca’s treatment for drug-resistance bacteria

April 12, 2016
Manufacturing and Production, Research and Development AstraZeneca, avibactam, ceftazidime, gram resistant

AstraZeneca has presented results from a series of trials which show the consistent efficacy of investigational antibiotic, ceftazidime-avibactam (CAZ-AVI) in …

News
roche

Roche’s Venclexta gets accelerated approval from US FDA for chronic lymphocytic leukemia

April 12, 2016
Manufacturing and Production, Research and Development, Sales and Marketing AbbVie, Roche, US FDA, Venclexta, chronic lymphocytic leukemia

Swiss drug firm Roche (SIX: ROG) on Tuesday said the US Food and Drug Administration (FDA) has granted accelerated approval …

News
shutterstock_4030507

Insys Therapeutics sees revenue from Subsys at $61-$62 million; shares plunge 21%

April 11, 2016
Business Services, Manufacturing and Production, Sales and Marketing Insys Therapeutics, Stock Price, Subsys, opioids, pain drug

Insys Therapeutics Inc (Nasdaq: INSY) stock plunged nearly 21% Monday after the company said sales for its pain drug will …

News
iqwigsmall

IQWiG says Gilead’s anti-HIV drug genvoya offers slightly lower benefits than competition

April 11, 2016
Medical Communications, Research and Development Bristol-Myers Squibb, Gilead, HIV, anti-HIV

German Institute for Quality and Efficiency in Health Care (IQWiG) said USdrug maker Gilead’s (Nasdaq: GILD) anti-HIV drug Genvoya provides marginally …

News
gwpharma

GW Pharma starts Phase III trials for Tuberous Sclerosis Complex drug

April 11, 2016
Research and Development Epidiolex, GW Pharmaceuticals, Tuberous Sclerosis Complex, genetics, rare disease

GW Pharmaceuticals Plc (Nasdaq: GWPH) said it has started late-stage trials for its Epidiolex (cannabidiol or CBD) to treat seizures …

News
mylan_building

Mylan launches new dosages of generic of Novartis hypertension drug in US

April 11, 2016
Manufacturing and Production Mylan, Novartis, generic, high blood pressure, hypertension

Mylan (TASE: MYL) has announced the US launch of new dosages of its generic version of Novartis’s hypertension drug, Lopressor …

News
handshake

Former US CEO of Boehringer Ingelheim becomes chairman at Inotek Pharmaceuticals

April 11, 2016
Medical Communications Boehringer Ingelheim, inotek, inotek pharma, j martin carroll

Inotek Pharmaceuticals has announced the appointment of J. Martin Carroll as the new chairman of the board. Carroll will succeed …

Appointment
stocks1

Weekly Movers: Array BioPharma, Amicus Therapeutics, Genocea Biosciences, Tesaro Inc, Incyte, Clovis Oncology

April 11, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Index, Movers, markets, stocks

Shares in Botox-maker Allergan (NYSE: AGN) plunged over 17% in intra-day trading as the $160 billion merger seal with US …

Feature
money_pills_2

Depomed criticised by investors and urged to explore potential sale

April 11, 2016
Sales and Marketing Depomed, board, horizon, sale, starboard, starboard value

Only a few short months after fighting off a $1 billion bid from Horizon Pharma, investors at Depomed have called …

News
cancerstudy

FDA staff raises doubts on efficacy, safety of Clovis’ trial drug for lung cancer, shares plunge

April 11, 2016
AstraZeneca, Clovis Oncology, US FDA, drug trial, lung cancer, regulation, rociletinib

Shares in Clovis Oncology Inc (Nasdaq: CLVS) plunged to close down nearly 18% after the US regulators expressed doubts if …

News
roche__tree

Roche’s cancer immunotherapy for lung cancer gets US FDA priority review

April 11, 2016
Business Services, Research and Development, Sales and Marketing Roche, US FDA, atezolizumab, lung cancer

Swiss drug firm Roche (SIX: ROG) on Monday said the US Food and Drug Administration (FDA) has accepted its Biologics …

News
chemo-web

Midatech launch treatment to reduce chemo-induced vomiting in the US

April 11, 2016
Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …

News
640px-eye_iris

Sun Pharma receives FDA approval for ocular pain treatment

April 11, 2016
Research and Development, Sales and Marketing FDA, Sun Pharma, bromsite, ocular treatment

Sun Pharma (BSE: 524715) has announced that their ocular pain prevention treatment, BromSite (bromfenac ophthalmic solution), has been approved by …

News
celgene-logo

Celgene says disappointed with NICE decision to not back blood cancer drug

April 8, 2016
Business Services, Medical Communications, Sales and Marketing

US drugmaker Celgene Corp (Nasdaq: CELG) on Friday said it is disappointed with UK regulators’ decision to not recommend Vidaza …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

HIV successfully overcomes CRISPR gene-editing technology

April 8, 2016
Research and Development HIV, crispr, failure, setback

Researchers using the CRISPR gene-editing technology have indicated that HIV can defeat efforts to cripple it, but have characterised it …

News
fda2outsideweb

US panel supports accelerated approval for Intercept’s trial drug for rare liver condition

April 8, 2016
Medical Communications, Research and Development, Sales and Marketing Intercept Pharmaceuticals, PDUFA, US FDA, liver disorder, rare disease

Intercept Pharmaceuticals (Nasdaq: ICPT) said a US Food and Drug Administration (FDA) advisory committee has recommended accelerated approval for its …

News
genome

UK’s genomics and personalised medicine expertise showcased at major international gathering

April 8, 2016
Manufacturing and Production, Research and Development 000 genomics project, 100, NHS, UK, expertise, genomics, international gathering, world leader

The UK’s expertise in genomics was showcased at a major international gathering to foster global collaboration in this burgeoning field. …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026